• Journal of the Korea Institute of Information Security & Cryptology
• /
• v.16 no.3
• /
• pp.129-141
• /
• 2006

The purpose of this paper is to design Conformance Test Suite for BSP(Biometric Service Provider) based on BioAPI(Biometric Application Programming Interface) v2.0. The proposed BioAPI Conformance Test Suite enables users to test BSP with framework independently. A test scheduling tool has been embodied to use Test Assertion in the form of XML. In order to demonstrate the performance of the Conformance Test Suite, the experiment was performed by using both verification and identification BSPs. As the results of this experiment, we were able to determinate whether BSPs based on BioAPI v2.0 satisfied standard requirements or not.

• Journal of Information Technology Services
• /
• v.10 no.3
• /
• pp.179-188
• /
• 2011

Biometrics is one of promising future technologies within personal identification area, and its application stretches to other variety industry site. Therefore it is necessary to test whether these products are implemented in conformance withe the BioAPI international standard specification. This paper presents the specific construction and application examples of BioAPI v2.0 conformance test suite according to the method described in ISO/IEC 24709. The problems and experience that have been discovered in the construction are described. Three BSP products claiming conformance to BioAPI was tested by proposed the test methodology and tools.

• 한국IT서비스학회:학술대회논문집
• /
• 2007.11a
• /
• pp.562-567
• /
• 2007

분산 환경에서 신분 확인을 위한 생체인증기기가 이용되는 경우 그 기기가 생체인증 표준인 BioAPI를 준용하여 제대로 구현된 것인가에 대한 적합성 시험이 필요하게 된다. 이러한 적합성 시험은 분산 환경의 사용자 및 서비스 제공자에게 표준 규격을 준용한 제품이라는 신뢰성을 주게 된다. 기존에 제공되는 있는 BioAPI(Biometric Application Programming Interface) v2.0 기반의 BSP(Biometric Service Provider)는 오프라인 상에서 BioAPI기반의 제품의 준용 여부만을 평가하기 때문에 분산 환경에서 여러 사람이 동시에 준용 여부를 평가 받기 힘들며 이에 따른 동시 서비스 제공도 불가능하다. 본 논문에서는 BioAPI v2.0 기반의 제품들이 분산 환경에서 제공되는 9개 모델의 표준화된 환경으로 구분하고, 원활한 적합성 시험을 위하여 XML기반의 Test Assertion을 설계하여 생체인증 API 표준 적합성을 시험하였다. XML Test Assertion을 이용한 생체인증 적합성 시험을 위한 메시지 플로우를 밝혀 그 타당성을 입증하였다.

• Food Science of Animal Resources
• /
• v.30 no.5
• /
• pp.804-810
• /
• 2010

This study was performed to select protease-producing Bacillus sp. as a potential probiotic starter for fermented meat products. In order to isolate protease-producing bacterium from meju, measured the diameter of the clear zone on agar plate (TSA, 1% (w/v) skim milk) and analyzed for intracellular protease activity, then 10 Bacillus-like strains were isolated. Three Bacillus-like strains (P19, P27, and P33) among 10 strains were able to tolerate in acidic condition (TSB, pH 2.5, 2 h incubation). These 3 strains were showed antimicrobial activity against food-borne pathogenic bacteria. These vegetative cells of 3 strains were showed a survival rate of 0.04% to 0.08% under the artificial gastric acidic condition (TSB, pH 2.5 with 1% (w/v) pepsin), but spore-forming cells were 56.29% to 84.77%. Vegetative cells of 3 strains were the least bile-resistant, while spore-forming cells of 3 strains showed higher survival rate more than 76% under artificial bile condition (TSB, 0.1% (w/v) oxgall bile). In these strains, P27 strain was finally selected as a good probiotic strain. P27 strain was tentatively identified as Bacillus amyloliquefaciens by API CHB kit and 16S rDNA sequence analysis. The results of this study suggest that B. amyloliquefaciens P27 can be used as a potential probiotic starter for fermented meat product.

• Korean Journal of Microbiology
• /
• v.46 no.2
• /
• pp.183-191
• /
• 2010

In this study, we isolated 179 bacterial strains using benzene, phenol, ethylbenzene, aniline, cumene, toluene as growth substrate from TCE contaminated soils and wastewaters. All the 179 strains were screened for TCE (30 mg/L) removal (growth substrate 0.2 g/L, $30^{\circ}C$, pH 7, cell biomass 1.0 g/L (w/v)) under aerobic condition for 21 days. EK2 strain using aniline showed the highest removal efficiency (74.4%) for TCE degradation. This strain was identified as Delftia acidovorans as the results of API kit, 16S rDNA sequence and fatty acid assay. In the batch culture, D. acidovorans EK2 showed the bio-degradation for TCE in the various TCE concentration (10 mg/L to 200 mg/L). However, D. acidovorans EK2 did not show the bio-degradation in the TCE 250 mg/L. D. acidovorans EK2 also show the removal efficiency (99.9%) for 12 days in the low concentration (1.0 mg/L). Optimal conditions to degrade TCE 200 mg/L were cell biomass 1.0 g/L (w/v), aniline 0.5 g/L, pH 7 and $30^{\circ}C$. Removal efficiency and removal rate by D. acidovorans EK2 strain was 71.0% and 94.7 nmol/h for 21 days under optimal conditions. Conclusion, we expect that D. acidovorans EK2 may contribute on the biological treatment in the contaminated soil or industrio us wastewater.

• Microbiology and Biotechnology Letters
• /
• v.35 no.2
• /
• pp.98-103
• /
• 2007

To isolate probiotic lactic acid bacteria for animal, we have screened the microorganisms from chicken feces, by random selection and agar well diffusion assay. Among them, CPM-7 strain showing superior inhibitory activity against Escherichia coli was selected. By examining carbohydrates utilization, morphologic property and 16S rRNA gene sequence, CPM-7 strain was identified as Lactobacillus salivarius, then named L. salivarius CPM-7. L. salivarius CPM-7 produced thirteen enzymes in the test using API ZYM kit, and showed resistance to low pH and bile salts. It survived at pH 2 for 30 min. and pH 3 for 6 hr. And, it was able to grow in MRS medium containing 0.2% (w/v) bile salts. L. salivarius CPM-7 adhered to the jejunal epithelium cells of pig. Both the supernatant of L. salivarius CPM-7 and the its neutralized one showed high inhibitory activity against E. coli K88.

• Food Science of Animal Resources
• /
• v.30 no.4
• /
• pp.634-640
• /
• 2010

The principal objective of this study was to screen and select acid-tolerant Lactobacillus strains from chicken feces, feeds, and other sources. Fourty six strains evidencing acid tolerance (pH 3.5) were isolated in this study. Among them, nine strains exhibited marked immunostimulatory effects. Therefore, nine candidate strains were characterized for probiotic use. In order to evaluate macrophage activation, NO production was measured using RAW 264.7 cells. In particular, three strains (FC812, FC222, and FC113) evidenced the highest levels of NO production measured at $38.39{\pm}20.01,\;35.06{\pm}27.73$, and $33.88{\pm}15.99{\mu}M$, respectively, at a concentration of $10^{8}CFU/mL$. The majority of strains, with the exception of strain FC322, evidenced marked resistance to artificial gastric juice (pH 2.5 with 1%(w/v) pepsin). Additionally, strains FC222, FC421, FC511, and FC721 were highly resistant to artificial bile acid (0.1%(w/v) oxgall), whereas strains FC113, FC322, FC422, FC621, and FC812 were the least resistant to bile. All nine strains exerted antimicrobial effects against chickenrelated pathogens. Additionally, all nine strains were found to be resistant to several antibiotics. The isolated strains, except for strain FC322, were tentatively identified as Lactobacillus salivarius, using an API 50 CHL kit. These results demonstrate that some probiotic organisms may potentially probiotic properties, and thus may serve as an effective alternative to antibiotics in animal applications.